导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 4.17% | 441/1050 |
| 近一周 | 0.83% | 192/1104 |
| 近一月 | -5.23% | 792/1103 |
| 近一季 | -15.60% | 876/1092 |
| 近半年 | 7.65% | 294/1070 |
| 近一年 | -4.42% | 650/1018 |
| 近两年 | 77.97% | 324/926 |
| 近三年 | 47.87% | 283/834 |
| 成立以来 | 37.20% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-9.13% 977/1070 |
53.41% 213/1101 |
- - |
- - |
| 2025 | 7.02% 858/1065 |
-6.75% 995/1014 |
-7.45% 994/1038 |
38.07% 227/1050 |
-10.18% 886/1065 |
| 2024 | 38.46% 5/1011 |
2.11% 205/960 |
-8.36% 802/983 |
19.80% 69/991 |
23.51% 6/1011 |
| 2023 | -35.05% 836/952 |
-7.20% 833/880 |
-0.25% 202/895 |
-20.48% 868/915 |
-11.77% 895/952 |
| 2022 | -26.48% 541/867 |
-19.18% 474/773 |
13.72% 156/806 |
-9.98% 240/845 |
-11.13% 808/867 |
| 2021 | -1.79% 377/740 |
-9.38% 476/580 |
28.88% 59/659 |
-7.19% 424/704 |
-9.39% 652/740 |
| 2020 | 59.97% 196/554 |
0.89% 140/419 |
25.40% 187/466 |
-1.48% 436/517 |
28.34% 45/554 |
| 2019 | 37.07% 242/410 |
21.42% 891/1149 |
-3.77% 632/1231 |
12.08% 78/390 |
4.67% 348/410 |
| 2018 | - - |
- - |
- - |
- - |
-5.77% 76/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 华夏优势精选股票 VS. 东吴新产业精选股票A(580008) |